Cambridge Advisors Inc. Bausch Health Companies Inc. Transaction History

Cambridge Advisors Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$20.52 - $26.45 $199,557 - $257,226	-9,725 Closed	0 $0
Q1 2019 Apr 16, 2019	BUY	$20.23 - $26.29 $196,736 - $255,670	9,725 New	9,725 $240,000
Q4 2018 Jan 29, 2019	SELL	$17.64 - $28.32 $173,313 - $278,244	-9,825 Closed	0 $0
Q3 2018 Oct 24, 2018	BUY	$20.64 - $25.67 $202,788 - $252,207	9,825 New	9,825 $252,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.72B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Cambridge Advisors Inc. with notifications on news.